Last reviewed · How we verify
NCT02713334
Cancer Patients Decision Making and Family Communication About Secondary Findings From Tumor Genomic Profiling
trial testing survey in Tumor Genomic Profiling in 495 participants. Participants enrolled and being followed up; not accepting new ones.
25 February 2026
Quick facts
| Lead sponsor | Memorial Sloan Kettering Cancer Center |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 495 |
| Start date | 25 February 2016 |
| Primary completion | 25 February 2026 |
| Estimated completion | 25 February 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- survey
- semi-structured interview
Conditions studied
- Tumor Genomic Profiling — all drugs for Tumor Genomic Profiling →
Sponsor
Memorial Sloan Kettering Cancer Center — full company profile →
Who can join
18 and older, any sex, with Tumor Genomic Profiling. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this protocol is to characterize cancer patients' responses to learning their secondary findings arising from tumor genomic profiling, and the process and outcomes of their decisions to communicate these results to their families.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT02713334
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of survey
Trials testing the same drug.
- NCT07340203 — Cross-Cultural Adaptation, Validity, and Reliability of the Wexner Questionnaire in Patients With Constipation · active not recruiting
- NCT07033390 — Monitor Orthopaedic Footwear Questionnaire (MOS) Validity and Reliability Study · enrolling by invitation
- NCT07012083 — Adherence to Anti-rabies Post-exposure Prophylactic Protocols · completed
- NCT06897865 — Nursing Students Education Virtual Reality Wound Care · not yet recruiting
- NCT06514443 — Barriers and Faciliators for Physical Activity in People With RMDs · not yet recruiting
Other Memorial Sloan Kettering Cancer Center trials
Trials by the same sponsor.
- NCT07566377 — Cord Blood Transplantation in Children and Young Adults With Blood Cancer · Phase 2 · recruiting
- NCT07507643 — A Study of Methylprednisolone in People Having Liver Surgery · Phase 3 · recruiting
- NCT07483307 — A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Breast Cancer · Phase 2 · recruiting
- NCT07459673 — HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term · Phase 2 · recruiting
- NCT07449195 — A Study Comparing Two Optical Coherence Tomography Devices in People With Ocular Tumors · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02713334 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center
- Last refreshed: 11 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02713334.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing